Abstract
Gene therapy has played an integral role in advancing our understanding of the central nervous system. However, gene therapy techniques have yet to be widely utilized in the peripheral nervous system. Critical targets for gene therapy within the PNS are the neurons in sympathetic ganglia, which are the final pathway to end organs. Thus they are the most specific targets for organ-specific neuron modification. This presents challenges because neurons are not viscerotopically organized within the ganglia and therefore cannot be targeted by their location. However, organ-specific neurons have been identified in sympathetic ganglia of some species and this offers an opportunity for targeting and transducing neurons by way of their target. In fact, alterations in sympathetic neurons have had pathological effects, and transducing organ-specific sympathetic neurons offer an exciting opportunity to selectively modify sympathetic pathology. In this chapter, we describe a method to virally transduce the celiac ganglion (CG), a prevertebral sympathetic ganglion that innervates abdominal organs, with AAV serotypes 1 and 6; thereby, providing a potential avenue to modulate specific subsets of neurons within the celiac ganglion.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Kaplitt MG, Leone P, Samulski RJ, Xiao X, Pfaff DW (1994) Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nat Genet 1–7
Blacklow NR, Hoggan MD, Kapikian AZ, Austin JB, Rowe WP (1968) Epidemiology of adenovirus-associated virus infection in a nursery population. Am J Epidemiol 88(3):368–378
Peel AL, Klein RL (2000) Adeno-associated virus vectors: activity and applications in the CNS. J Neurosci Methods 98(2):95–104
Ruitenberg MJ, Eggers R, Boer GJ, Verhaagen J (2002) Adeno-associated viral vectors as agents for gene delivery: application in disorders and trauma of the central nervous system. Methods 28(2):182–194
Chamberlin NL, Du Du B, de Lacalle S, Saper CB (1998) Recombinant adeno-associated virus vector: use for transgene expression and anterograde tract tracing in the CNS. Brain Res 793(1-2):169–175
Glatzel M, Flechsig E, Navarro B, Klein MA, Paterna JC, Büeler H et al (2000) Adenoviral and adeno-associated viral transfer of genes to the peripheral nervous system. Proc Natl Acad Sci U S A 97(1):442–447
Mason MR, Ehlert EM, Eggers R, Pool CW, Hermening S, Huseinovic A et al (2010) Comparison of AAV serotypes for gene delivery to dorsal root ganglion neurons. Mol Ther 18(4):715–724
Macrae IM, Furness JB, Costa M (1986) Distribution of subgroups of noradrenaline neurons in the coeliac ganglion of the guinea-pig. Cell Tissue Res 244(1):1–8
Quinson N, Robbins HL, Clark MJ, Furness JB (2001) Locations and innervation of cell bodies of sympathetic neurons projecting to the gastrointestinal tract in the rat. Arch Histol Cytol 64(3):281–294
Browning KN, Zheng Z, Kreulen DL, Travagli RA (1999) Two populations of sympathetic neurons project selectively to mesenteric artery or vein. Am J Physiol Heart Circ Physiol [Bethesda, Md.]. American Physiological Society; 45(4):H1263–H1272
Richardson RJ, Grkovic I, Allen AM, Anderson CR (2006) Separate neurochemical classes of sympathetic postganglionic neurons project to the left ventricle of the rat heart. Cell Tissue Res 324(1):9–16
Keast JR, McLachlan EM, Meckler RL (1993) Relation between electrophysiological class and neuropeptide content of guinea pig sympathetic prevertebral neurons. Journal of Neurophysiology Am Physiological Soc; 69(2):384–394
Fink GD. (2009). Arthur C. Corcoran Memorial Lecture. Sympathetic activity, vascular capacitance, and long-term regulation of arterial pressure. Hypertension,, 307–12. PMCID: PMC2685147
Kandlikar SS, Fink GD (2011) Splanchnic sympathetic nerves in the development of mild DOCA-salt hypertension. AJP: Heart and Circulatory Physiology 301(5):H1965–H1973
Greene LA, Tischler AS. (1976). Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proceedings of the National Academy of Sciences of the United States of America, 73(7):2424–2428. PMCID:PMC430592
Acknowledgement
This work was supported by NIH grant P01HL070687.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media New York
About this protocol
Cite this protocol
Hammond, B., Kreulen, D.L. (2016). Gene Therapy of the Peripheral Nervous System: Celiac Ganglia. In: Manfredsson, F. (eds) Gene Therapy for Neurological Disorders. Methods in Molecular Biology, vol 1382. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-3271-9_20
Download citation
DOI: https://doi.org/10.1007/978-1-4939-3271-9_20
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-3270-2
Online ISBN: 978-1-4939-3271-9
eBook Packages: Springer Protocols